The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions

Current Medical Research and Opinion

Volumn 19, Issue 3, 2003, Pages 178-186

  Zhao, Lian ^a   Bath, Philip M W ^a   Fox, Sue ^a   May, Jane ^a   Judge, Heather ^a   Lösche, Wolfgang ^b   Heptinstall, Stan ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Abciximab; MK 852; Monocytes; Platelets; Tissue factor

Indexed keywords

ABCIXIMAB; ACETYLCYSTEINYLASPARAGINYL 5,5 DIMETHYLTHIOPROLYL 4 AMINOMETHYLPHENYLALANYLGLYCYLASPARTYLCYSTEINE; ACETYLSALICYLIC ACID; AR C69931; DIPYRIDAMOLE;

ARTICLE; CELL INTERACTION; DRUG POTENTIATION; HUMAN; LEUKOCYTE; LEUKOCYTE ACTIVATION; MONOCYTE; NORMAL HUMAN; PROTEIN EXPRESSION; THROMBOCYTE; VASCULAR DISEASE;

ADENOSINE MONOPHOSPHATE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD11B; ASPIRIN; BLOOD PLATELETS; DIPYRIDAMOLE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LEUKOCYTES; MONOCYTES; NEUTROPHILS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THIAZOLIDINES; THROMBOPLASTIN;

EID: 0038583507     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079903125001721     Document Type: Article

References (38)

1. Davies M, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med. 1984;310:1137-40
2. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84:613-17
3. Heptinstall S. The importance of platelet aggregation in coronary heart disease. Br J Cardiol 2000;7:S27-S30
4. Eisenberg PR, Ghigliotti, G. Platelet-dependent and procoagulant mechanisms in arterial thrombosis. Int J Cardiol 1999;68(Suppl 1):S3-10
5. Patrono C, Coller B, Dalen J, FitzGerald GA, Fuster V, Gent M, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 2001;119(1):39S-63S
6. Diener H, Cunha L, Forbes C. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13
7. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK and The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502
8. Steinhubl SR, Berger PB, Mann JT, 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-20
9. Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet 1999;353:227-31
10. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, de Feyter PJ, Specchia G, Ruzyllo W. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000;21:1406-32
11. Berkowitz B. Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease. Haemostasis 2000;30(Suppl 3):27-43
12. Chew DP, Bhatt DL, Sapp S, Topol EJ. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists - a meta-analysis of phase III multicenter randomized trials. Circulation 2001;103:201-6
13. Hamburger S, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-4
14. Sako D, Chang XJ, Barone KM, Vachino G, Shaw G, Veldman T, Bean KM, Furie B, Ahern TJ, Cummings DA, Larsen GR. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 1993;75:1179-86
15. Nemerson Y. Tissue factor and hemostasis. Blood 1988;71:1-8
16. Camerer E, Kolsto A-B, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996;81:1-41
17. Leatham EW, Bath PM, Tooze JA, Camm AJ. Increased monocyte tissue factor expression in coronary disease. Br Heart J 1995;73:10-3
18. Humphries RG, Robertson MJ, Leff P. A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. Trends Pharm Sci 1995;16:179-81
19. Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996;75:87-95
20. Peters MJ, Dixon G, Kotowicz KT, Hatch DJ, Heyderman RS, Klein NJ. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br J Haematol 1999;106:391-9
21. Sanderson HM, Fox SC, Robbins RA, Losche W, Spangenberg P, Heptinstall S. Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood. Platelets 1998;9:245-50
22. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999;34:1420-6
23. Li N, Hu H, Lindqvist M, Wikstrom-Jonsson E, Goodall AH, Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arterioscler Thromb Vasc Biol 2000;20:2702-8
24. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000;20:2322-8
25. Zillmann A, Luther T, Muller I, Kotzsch M, Spannagl M, Kauke T, Oelschlagel U, Zahler S, Engelmann B. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001;281:603-9
26. Li N, Goodall AH, Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates. Br J Haematol 1997;99:808-16
27. Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JR. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thromb Haemost 1982;48:327-9
28. Pejler G, Geczy CL. Human peripheral blood mononuclear cells require factor X and platelets for expression of prothrombinase activity in response to bacterial lipopolysaccharide. Ann Hematol 2001;80:278-83
29. Spangenberg P, Redlich H, Bergmann I, Losche W, Gotzrath M, Kehrel B. The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost 1993;70:514-21
30. Kuijper PHM, Torres HIG, Lammers JWJ, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions. Thromb Haemost 1998;80:443-8
31. Redlich H, Vickers J, Losche W, Heptinstall S, Kehrel B, Spangenberg P. Formation of platelet-leukocyte conjugates in whole blood. Platelets 1997;8:419-25
32. Xiao Z, Theroux P, Frojmovic M. Modulation of platelet-neutrophil interaction with pharmacological inhibition of fibrinogen binding to platelet GPIIb/IIIa receptor. Thromb Haemost 1999;81:281-5
33. Scholz T, Zhao L, Temmler U, Bath P, Heptinstall S, Losche W. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro. Platelets 2002;13:401-6
34. Mickelson JK, Ali MN, Kleiman NS, Lakkis NM, Chow TW, Hughes BJ, Smith CW. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty. J Am Coll Cardiol 1999;33:97-106
35. Fredrickson BJ, Turner NA, Kleiman NS, Graziadei N, Maresh K, Mascelli MA, Effron MB, McIntire LV. Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty. Circulation 2000;101:1122-9
36. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000;96:170-5
37. Zhao L, Bath P, Heptinstall S. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. Br J Pharmacol 2001; 134:353-8
38. 12 play a role in controlling shape change in human platelets. Platelets 2003;14:15-20